Pre-transplant factors associated with mortality after lung transplantation in cystic fibrosis: A systematic review and meta-analysis
- PMID: 30482682
- DOI: 10.1016/j.jcf.2018.10.013
Pre-transplant factors associated with mortality after lung transplantation in cystic fibrosis: A systematic review and meta-analysis
Abstract
Background: Mortality risk stratification is essential in lung transplantation (LTx) to allow listing, prioritization and mitigating strategies. In cystic fibrosis (CF) patients, predictors of post-LTx mortality are not established.
Methods: For this systematic review and meta-analysis, seven databases were searched until January 3, 2018 to identify predictors of post-LTx mortality in CF. We excluded studies of multi-organ transplantation, re-transplantation and graft survival. For multiple studies assessing the same population during overlapping time-periods, the largest one was analyzed. Risk of bias was assessed with the Newcastle-Ottawa scale (NOS). Pooled hazard ratios were calculated using random-effects models.
Results: Fifty-four studies were included in the systematic review and 11 studies in the meta-analyses (low-to-moderate bias risk, NOS score ≥ 5). Among 10 factors assessed in the meta-analysis, B. cepacia complex (BCC) (N = 1451, unadjusted HR = 2.35, 95%CI:1.80-3.06; I2 = 20.4% and adjusted HR = 2.49, 95%CI:1.74-3.57; I2 = 46.2%) and ascending chronological year of LTx (N = 4207, unadjusted HR = 0.98, 95%CI:0.97-0.98, I2 = 4.8%) were predictors of post-LTx mortality. Male gender (N = 2903, adjusted HR = 1.12, 95%CI:1.0-1.26, I2 = 0%) and age in adults (N = 3677, unadjusted HR = 0.99, 95%CI:0.97-1.00; I2 = 64.1% and N = 2605, adjusted HR = 0.98, 95%CI:0.97-0.99; I2 = 34.3%) had borderline significant associations with post-LTx mortality. P. aeruginosa colonization, forced expiratory volume in one second (FEV1), pulmonary hypertension, body mass index (BMI), pancreatic insufficiency and CF-related diabetes (CFRD) were not predictors of mortality.
Conclusions: BCC was associated with a higher post-LTx mortality whereas FEV1, pulmonary hypertension, BMI, CFRD and female gender were not associated with post-LTx mortality. These findings indicate that CF-specific risk estimates of post-LTx mortality should be considered.
Keywords: Cystic fibrosis; Lung transplantation; Mortality; Predictors.
Copyright © 2018 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.
Similar articles
-
Heterogeneity in Survival in Adult Patients With Cystic Fibrosis With FEV1 < 30% of Predicted in the United States.Chest. 2017 Jun;151(6):1320-1328. doi: 10.1016/j.chest.2017.01.019. Epub 2017 Jan 20. Chest. 2017. PMID: 28115168 Free PMC article.
-
Survival and Lung Transplant Outcomes for Individuals With Advanced Cystic Fibrosis Lung Disease Living in the United States and Canada: An Analysis of National Registries.Chest. 2021 Sep;160(3):843-853. doi: 10.1016/j.chest.2021.04.010. Epub 2021 Apr 17. Chest. 2021. PMID: 33878343 Free PMC article.
-
Mortality Risk and Pulmonary Function in Adults With Cystic Fibrosis at Time of Wait Listing for Lung Transplantation.Ann Thorac Surg. 2015 Aug;100(2):474-9. doi: 10.1016/j.athoracsur.2015.04.022. Epub 2015 Jun 30. Ann Thorac Surg. 2015. PMID: 26138770
-
Should cystic fibrosis patients infected with Burkholderia cepacia complex be listed for lung transplantation?Interact Cardiovasc Thorac Surg. 2011 Dec;13(6):631-4. doi: 10.1510/icvts.2011.271874. Epub 2011 Sep 14. Interact Cardiovasc Thorac Surg. 2011. PMID: 21920934 Review.
-
Indications for lung resection surgery and lung transplant in South American children with cystic fibrosis.Paediatr Respir Rev. 2018 Jan;25:37-42. doi: 10.1016/j.prrv.2017.02.001. Epub 2017 Feb 16. Paediatr Respir Rev. 2018. PMID: 28366682 Review.
Cited by
-
Lung Transplantation in a New Era in the Field of Cystic Fibrosis.Life (Basel). 2023 Jul 21;13(7):1600. doi: 10.3390/life13071600. Life (Basel). 2023. PMID: 37511977 Free PMC article. Review.
-
Health-related quality of life following lung transplantation for cystic fibrosis: A systematic review.Clinics (Sao Paulo). 2023 Apr 1;78:100182. doi: 10.1016/j.clinsp.2023.100182. eCollection 2023. Clinics (Sao Paulo). 2023. PMID: 37011456 Free PMC article.
-
Management of Multidrug Resistant Infections in Lung Transplant Recipients with Cystic Fibrosis.Infect Drug Resist. 2021 Dec 10;14:5293-5301. doi: 10.2147/IDR.S301153. eCollection 2021. Infect Drug Resist. 2021. PMID: 34916813 Free PMC article. Review.
-
Cystic fibrosis survival outcomes following second lung transplant: The north American experience.Clin Transplant. 2023 Nov;37(11):e15097. doi: 10.1111/ctr.15097. Epub 2023 Aug 10. Clin Transplant. 2023. PMID: 37563332 Free PMC article.
-
Antibiotic Therapy for Difficult-to-Treat Infections in Lung Transplant Recipients: A Practical Approach.Antibiotics (Basel). 2022 May 2;11(5):612. doi: 10.3390/antibiotics11050612. Antibiotics (Basel). 2022. PMID: 35625256 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical